Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease

Cite Embed

Aaron Waxman discusses research into patients with pulmonary hypertension due to interstitial lung disease and the effects of inhaled treprostinil.  Aaron B. Waxman is the director of the Pulmonary Vascular Disease Program at Brigham and Women’s Hospital (BWH). He is also an associate professor of medicine at Harvard Medical School.

Image courtesy of Aaron Waxman

Image courtesy of the interviewee


Report Infringement

Sign-up

Leave a Reply

Your email address will not be published. Required fields are marked *

×
Many colleges and universities have institutional memberships. If you are affiliated with a subscribing institution, please access Faculti through your on-campus or proxy IP address. Alternatively, as a Guest, you have insight(s) remaining for this month. Register for free and view thousands of insights in our archive today.
Related Posts
error:

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×